Affiliation:
1. Academician E.A. Wagner Perm State Medical University of the Ministry of Healthcare of Russia
2. Stavropol State Medical University of the Ministry of Healthcare of Russi
3. Samara Regional Clinical Cardiology Dispensary
Abstract
During the COVID-19 pandemic, many familiar processes had to be adapted due to various restrictions and high workload on healthcare workers. In particular, to reduce the risk of coronavirus infection, remote patient care technologies have been used more frequently. This study aims to analyze the impact of the COVID-19 pandemic and related restrictions on access to free educational courses on diabetes, disease dynamics, and patient awareness of necessary treatment methods. Changes in patient satisfaction with online learning compared to traditional face-to-face formats were studied, as well as changes in medication adherence with regular education and consultations. The authors described possible reasons for changes in the effectiveness of education and proposed measures to optimize treatment processes and patient information in Russia. The study showed that the COVID-19 pandemic led to a decrease in patient participation in educational programs on diabetes. This could have been due to fear of infection, lack of awareness of such programs, and socio-economic inequality.
Publisher
Medical Informational Agency Publishers
Reference20 articles.
1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) What is diabetes? Diabetes Overview. 2016.
2. Howard-Thompson A. et al. Type 2 diabetes mellitus: outpatient insulin management. American Family Physician. 2018;97(1):29– 37. DOI: 10.13655/1.6.1234567
3. Roglic G. Diabetes. World Health Organization (WHO). 2022.
4. Dedov I.I., Kontsevaya A.V., Shestakova M.V., Belousov Yu.B., Balanova Yu.A., Khudyakov M.B., Karpov O.I. Economic burden of type 2 diabetes and its major cardiovascular complications in the Russian Federation. Sakharnyy diabet. 2016;19(6):518–526. (In Russian). DOI: 10.13655/1.6.1234567
5. Popovich L.D., Shestakova M.V., Potapchik E.G., Mayorov A.Yu., Vikulova O.K. Is it beneficial for the state to provide diabetic patients on insulin therapy with self-monitoring blood glucose devices according to regulatory needs? Sakharnyy diabet. 2017;20(2):108–118. (In Russian). DOI: 10.13655/1.6.1234567